Abstract Topics

ABSTRACT TOPICS

Abstract submission is now CLOSED.

  • Dementia and the Convention on Human Rights of Persons with Disabilities (CPRD) NEW
  • Dementia and equitable society NEW
  • Dementia and human rights NEW
  • Dementia and labour laws NEW
  • Dementia and NCDs, SDGs, UHC and ageing NEW
  • Dementia policies and public policy
  • Designing and evaluating the impact of funding programmes NEW
  • Economics of dementia
  • Engaging people with dementia and carers in policy
  • Attitudes, awareness and stigma
  • Community partnerships / Public-Private-People partnerships NEW
  • Consumer empowerment
  • Dementia friendliness
  • Diverse populations – inclusion, equality, cultural issues
  • Fundraising for dementia NEW
  • Cognitive reserve, brain resilience and dementia prevention NEW
  • Implementation of risk reduction interventions (Local, regional and national levels)
  • Public health campaigning NEW
  • Risk factors
  • Risk reduction and prevention (including clinical trials)
  • Diagnosis
  • Diagnostic tools
  • Dementia and dignity
  • Dementia and spirituality
  • End of life and palliative care
  • Environment and architecture for dementia
  • Models of care
  • Post diagnostic support for people with dementia and carers NEW
  • Psychosocial interventions
  • Rehabilitation (physical and cognitive)
  • Social isolation, loneliness, depression and the consequences for people with dementia and carers NEW
  • Well being and quality of life
  • Education and training in hospitals NEW
  • Formal carers education and training
  • Informal carers support – pre, during and post
  • Informal carers training
  • Polypharmacy NEW
  • Role of primary care NEW
  • Young carers NEW
  • Global Dementia Observatory (GDO) NEW
  • International collaboration on data sharing NEW
  • Registries
  • Clinical trials NEW
  • Epidemiology
  • Genetics
  • Inflammation and immunity NEW
  • Innovation, entrepreneurship and technology
  • Mid-to-late stages of dementia NEW
  • Mild Cognitive Impairment (MCI)
  • New and future treatments
  • Non-pharmacological interventions
  • Other syndromes and dementia NEW
  • Young onset dementia